Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to ...

Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system ...

A Davie mom fighting a rare and rapidly spreading cancer is enrolled in a pioneering clinical trial at Memorial Cancer ...

The future is bright for prostate cancer research. It's glowing, in fact, thanks to new tools that combine the eye-catching ...

Scientists have created a new nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. To make the therapy even ...

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

“Nutrient constraints do not just impact the metabolism of cancer cells,” Dr. Alexander Muir, assistant professor at the University of Chicago, told Technology Networks. “Anti-tumor immune cells are ...

The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...